The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(4-Benzothiazol-2-yl-2-methyl-phenyl)-1H-benzotriazole ID: ALA3818240
PubChem CID: 127051829
Max Phase: Preclinical
Molecular Formula: C20H14N4S
Molecular Weight: 342.43
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(-c2nc3ccccc3s2)ccc1-n1nnc2ccccc21
Standard InChI: InChI=1S/C20H14N4S/c1-13-12-14(20-21-16-7-3-5-9-19(16)25-20)10-11-17(13)24-18-8-4-2-6-15(18)22-23-24/h2-12H,1H3
Standard InChI Key: ZRDWMRSXWUJMQU-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 29 0 0 0 0 0 0 0 0999 V2000
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1852 -2.6281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2781 -3.8165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8565 -5.2005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3443 -5.3916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2537 -4.1987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6753 -2.8147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0879 -3.6632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1413 -8.0438 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.9230 -6.7763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3512 -7.0908 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4957 -8.5772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1229 -9.1692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7115 -9.4626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5281 -10.9712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1553 -11.5632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9324 -10.6610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
1 5 1 0
6 7 1 0
7 8 2 0
8 9 1 0
5 9 2 0
4 6 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
10 15 2 0
11 16 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 1 0
17 21 1 0
22 23 1 0
23 24 2 0
24 25 1 0
21 25 2 0
20 22 2 0
13 18 1 0
1 10 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 342.43Molecular Weight (Monoisotopic): 342.0939AlogP: 5.01#Rotatable Bonds: 2Polar Surface Area: 43.60Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 2.12CX LogP: 5.76CX LogD: 5.76Aromatic Rings: 5Heavy Atoms: 25QED Weighted: 0.45Np Likeness Score: -2.24
References 1. Senadi GC, Liao C, Kuo K, Lin J, Chang L, Wang JJ, Hu W. (2016) Design, synthesis and antimetastatic evaluation of 1-benzothiazolylphenylbenzotriazoles for photodynamic therapy in oral cancer cells, 7 (6): [10.1039/C6MD00034G ]